BeOne Medicines Ltd
221 hedge funds and large institutions have $8.11B invested in BeOne Medicines Ltd in 2019 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 66 increasing their positions, 76 reducing their positions, and 19 closing their positions.
163% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 19
32% more capital invested
Capital invested by funds: $6.12B → $8.11B (+$1.99B)
13% more funds holding
Funds holding: 196 → 221 (+25)
0.13% less ownership
Funds ownership: 6.4% → 6.27% (-0.13%)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
13% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 76
72% less call options, than puts
Call options by funds: $16.8M | Put options by funds: $59.2M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$166M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$69.9M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
+$58.4M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$16.4M |
| 5 |
Millennium Management
New York
|
+$11.8M |
Top Sellers
ONC Hedge Fund Activity: Q4 2019 in Review
221 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q4 2019, worth a combined $8.11B — up 32% from $6.12B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new ONC positions and 19 closed out — a net gain of 31 holders — while 66 added to existing stakes and 76 trimmed.
The largest buyer was Capital International Investors, adding an estimated $166M. The largest seller was Myriad Asset Management, exiting entirely with an estimated $120M sold.
- 221 institutional investors held BeOne Medicines Ltd (ONC) as of Q4 2019, up from 196 in Q3 2019.
- Funds reported $8.11B of BeOne Medicines Ltd stock for Q4 2019, up 32% quarter-over-quarter.
- 50 funds opened new BeOne Medicines Ltd positions in Q4 2019 and 19 closed out, a net change of +31 holders.
- The largest BeOne Medicines Ltd buyer in Q4 2019 was Capital International Investors, an estimated $166M added.
- The largest BeOne Medicines Ltd seller in Q4 2019 was Myriad Asset Management, an estimated $120M sold.
Based on aggregated 13F filings for Q4 2019.